The earnings call reflected a positive sentiment, with the company raising its full year guidance, launching successful new products, and maintaining a focus on debt reduction. However, challenges remain in specific segments like Dental and Purification and Filtration, and Q4 guidance came in below expectations.

Company Guidance

During the third quarter 2024 earnings call for Solventum, the company provided updated guidance, reflecting their continued transformation efforts and strong performance. Solventum reported positive top-line growth despite challenging year-over-year comparisons and raised their full-year organic growth forecast to the upper half of their previous guidance range of flat to 1%. Additionally, they increased their adjusted EPS and free cash flow guidance ranges. The company saw sequential improvement in operating margins, aided by some one-time items that offset headwinds from the 3M supply agreement markups. Solventum also focused on debt reduction, paying down $200 million during the quarter. Looking forward, they plan to share their long-range plan and 2025 guidance in the fourth quarter 2024 earnings call, highlighting their strategic market selection and growth initiatives.

Increased Full Year Guidance

Solventum raised its full year organic growth rate to the upper half of the prior guidance of flat to 1%, and increased adjusted EPS and free cash flow guidance ranges.

Debt Reduction

The company paid down $200 million of debt during the quarter, maintaining its commitment to an investment-grade rating and prioritizing debt paydown.

Product Innovations

Successful launch of several products, including the Peel and Place dressing in MedSurg, Clinpro Clear Fluoride Treatment in Dental, and AI-driven Solventum Revenue Integrity system in Health Information Systems.

Segment Performance

MedSurg saw a 1% organic sales increase, driven by adoption of antimicrobial IV site management solutions and positive trends in OEM products.

---

Solventum Corporation (SOLV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SOLV Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
May 09, 2024	2024 (Q1)	1.75 / 2.08	1.696	22.64% (+0.38)		―
Aug 08, 2024	2024 (Q2)	1.50 / 1.56	1.859	-16.08% (-0.30)	―
Nov 07, 2024	2024 (Q3)	1.39 / 1.64	2.664	-38.44% (-1.02)
Feb 27, 2025	2024 (Q4)	1.31 / -	2.311	―	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

SOLV Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 07, 2024	$75.07	$72.43	-3.52%
Aug 08, 2024	$58.66	$60.59	+3.29%
May 09, 2024	$66.43	$64.83	-2.41%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---